Forecasting mortality: Dynamic assessment of risk in ST-segment elevation acute myocardial infarction

European Heart Journal

Volumn 27, Issue 4, 2006, Pages 419-426

  Chang, Wei Ching ^a   Kaul, Padma ^a   Fu, Yuling ^a   Westerhout, Cynthia M ^a   Granger, Christopher B ^b   Mahaffey, Kenneth W ^b   Wallentin, Lars ^c   Van De Werf, Frans ^d   Armstrong, Paul W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Dynamic modelling; Myocardial infarction; Prognosis; Simplified risk scores; ST segment elevation

Indexed keywords

ABCIXIMAB; ENOXAPARIN; HEPARIN; PEXELIZUMAB; TENECTEPLASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEASIBILITY STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; ST SEGMENT ELEVATION; VALIDATION STUDY;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; REGRESSION ANALYSIS; RISK ASSESSMENT; THROMBOLYTIC THERAPY;

EID: 32144456549     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi700     Document Type: Article

References (20)

1. Chang W-C, Boersma E, Granger CB, Harrington RA, Califf RM, Simoons ML, Kleinman NS, Armstrong PW, for the GUSTO IIb and PURSUIT Investigators. Dynamic prognostication in non-ST elevation acute coronary syndromes: insights from GUSTO IIb and PURSUIT. Am Heart J 2004;148:62-71.
2. Redelmeier DA, Lustig AJ. Prognostic indices in clinical practice. JAMA 2001;285:3024-3025.
3. Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001;358:605-613.
4. Wallentin L, Goldstein P, Armstrong PW, Granger CB, Adgey AA, Arntz HR, Bogaerts K, Danays T, Lindahl B, Makijarvi M, Verheugt F, Van de Werf F. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 2003;108:135-142.
5. Granger CB, Mahaffey KW, Weaver WD, Theroux P, Hochmann JS, Filloon TG, Rollins S, Todaro TG, Nicolau JC, Ruzyllo W, Armstrong PW, for the COMMA Investigators. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial. Circulation 2003;108:1184-1190.
6. Armstrong PW, Wagner G, Goodman SG, Van de Werf F, Granger C, Wallentin L, Fu Y, for the ASSENT 3 Investigators. ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction. Eur Heart J 2003;24:1515-1522.
7. Fu Y, Goodman S, Chang W-C, Van de Werf F, Granger CB, Armstrong PW, for the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Trial Investigators. Time to treatment influences the impact of ST-segment resolution on one-year prognosis. Insight from the ASSENT-2 Trial. Circulation 2001;104:2653-2659.
8. Hindman NB, Schocken DD, Widmann M, Anderson WD, White RD, Leggett S, Ideker RE, Hinohara T, Selvester RH, Wagner GS. Evaluation of a QRS scoring system for estimating myocardial infarct size. V. Specificity and method of application of the complete system. Am J Cardiol 1985;55:1485-1490.
9. Schroder R, Wegscheider K, Schroder K, Dissmann R, Meyer-Sabellek W, for the INJECT trial group. Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. J Am Coll Cardiol 1995;26:1657-1664.
10. Morrow DA. New insight into clinical risk scores for patients with acute coronary syndromes. Am Heart J 2003;146:754-756.
11. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, Giugliano RP, McCabe CH, Braunwald E. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation: An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation 2000;102:2031-2037.
12. Steyerberg EW, Harrell FE Jr, Borsboom GJ, Eijkemans MJ, Vergouwe Y, Habbema JD. Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol 2001;54:774-781.
13. Moons KGM, Harrell FE. Letter to the Editor: Should scoring rules be based on odds ratios or regression coefficients? J Clin Epidemiol 2002;55:1054-1055.
14. Morrow DA, Antman EM, Giugliano RP, Cairns R, Charlesworth A, Murphy SA, de Lemos JA, McCabe CH, Braunwald E. A simple risk index for rapid initial triage of patients with ST-elevation myocardial infarction: an InTIME II Substudy. Lancet 2001;358:1571-1575.
15. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, Van de Werf F, Avezum A, Goodman SG, Flather MD, Fox KA, for the Global Registry of Acute Coronary Events (GRACE) Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 2003;163:2345-2353.
16. Newby LK, Hasselblad V, Armstrong PW, Van de Werf F, Mark DB, White HD, Topol EJ, Califf RM. Time-based risk assessment after myocardial infarction. Implications for timing of discharge and applications to medical decision-making. Eur Heart J 2003;24:182-189.
17. Walter LC, Brand RJ, Counsell SR, Palmer RM, Landefeld CS, Fortinsky RH, Covinsky KE. Development and validation of a prognostic index for 1-year mortality in older adults after hospitalization. JAMA 2001;285:2987-2994.
18. Pelter MM, Adams MG, Drew BJ. Computer versus manual measurement of ST-segment deviation. J Electrocardiol 1997;30:151-156.
19. Ui S, Chino M, Isshiki T. Rates of primary percutaneous coronary intervention worldwide. Circ J 2005;69:95-100.
20. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM, for the GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41021 patients. Circulation 1995;91:1659-1668.